Drug Eluting Stents Market Size, Share and Forecast 2026
The Drug Eluting Stents market was valued at USD XX million in 2018 and expected to grow at a CAGR of XX% to reach a market value of USD XX million by 2026.
(EMAILWIRE.COM, September 13, 2019 ) Market Overview:
Stents are small mesh tubes inserted to keep arteries open after a procedure called angioplasty (percutaneous coronary intervention). A drug-eluting stent (DES) is a coronary or peripheral stent placed in a narrowed, diseased coronary or peripheral arteries and slowly releases a drug to prevent fibrosis that when coupled with clots could block the stented artery.
Market Dynamics:
The global market for the Drug Eluting Stents Market is primarily driven by growing incidences of cardiovascular diseases (CVD), the rising geriatric population, and a growing number of government initiatives like favorable reimbursement policies.
However, the stringent regulations for the approval process, alternative treatment for drug-eluting stents and the products high cost may hinder market progress.
Market Segmentation:
By Coating
• Polymer-based coating stents
• Polymer-free coating stents
By Application
• Coronary Artery Diseases
• Peripheral Artery Disease
By End-user
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• Boston Scientific Corp.
• Abbott Laboratories
• Medtronic Plc
• Biotronik Inc.
• Johnson & Johnson
• MicroPort Scientific Corporation
• Others
View full report: https://www.datamintelligence.com/research-report/drug-eluting-stents-market
Download free sample: https://www.datamintelligence.com/download-sample/drug-eluting-stents-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Stents are small mesh tubes inserted to keep arteries open after a procedure called angioplasty (percutaneous coronary intervention). A drug-eluting stent (DES) is a coronary or peripheral stent placed in a narrowed, diseased coronary or peripheral arteries and slowly releases a drug to prevent fibrosis that when coupled with clots could block the stented artery.
Market Dynamics:
The global market for the Drug Eluting Stents Market is primarily driven by growing incidences of cardiovascular diseases (CVD), the rising geriatric population, and a growing number of government initiatives like favorable reimbursement policies.
However, the stringent regulations for the approval process, alternative treatment for drug-eluting stents and the products high cost may hinder market progress.
Market Segmentation:
By Coating
• Polymer-based coating stents
• Polymer-free coating stents
By Application
• Coronary Artery Diseases
• Peripheral Artery Disease
By End-user
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• Boston Scientific Corp.
• Abbott Laboratories
• Medtronic Plc
• Biotronik Inc.
• Johnson & Johnson
• MicroPort Scientific Corporation
• Others
View full report: https://www.datamintelligence.com/research-report/drug-eluting-stents-market
Download free sample: https://www.datamintelligence.com/download-sample/drug-eluting-stents-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results